✦ LIBER ✦

Issues for statisticians in pharmaco-economic evaluations

✍ Scribed by A. P. Grieve

Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 98 KB
Volume: 17
Category: Article
ISSN: 0277-6715
DOI: 10.1002/(sici)1097-0258(19980815/30)17:15/16<1715::aid-sim973>3.0.co;2-6

No coin nor oath required. For personal study only.

✦ Synopsis

Economic evaluations of new pharmaceutical products are of increasing importance to pharmaceutical companies. In this paper we investigate a number of topics of greater or lesser importance to statisticians who need to involve themselves in pharmaco-economic evaluations. These range from the need to consider whether traditional randomized clinical trials provide the most appropriate setting for an economic evaluation, to the more technical question of how to handle cost-effectiveness ratio data, including the issue of the most appropriate inferential apparatushypothesis testing, confidence intervals or Bayesian methods.

📜 SIMILAR VOLUMES

A model to correct for short-run ineffic

A model to correct for short-run inefficiencies in economic evaluations in healthcare

✍ Gijs Van de Wetering; Willem H. Woertman; Eddy M. M. Adang 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB 👁 1 views

## SUMMARY Important assumptions that underlie cost‐effectiveness analysis (CEA) are that production technologies are convex and that production processes always perform at constant returns to scale. However, in the short run these assumptions are likely to be violated. Therefore, CEAs might overes

Issues in the design of studies for the

Issues in the design of studies for the economic evaluation of new atypical antipsychotics: the ESTO study

✍ M.F. Drummond; M.R.J. Knapp; T.P. Burns; K.D. Miller; P. Shadwell 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 1 views

Background: Increasing attention is being focused on the costs of healthcare and the need for cost-effective treatments. Drugs for schizophrenia have not escaped this scrutiny, especially now that several new agents are available, with acquisition costs substantially higher than for established ther

Correcting for compensating mechanisms r

Correcting for compensating mechanisms related to productivity costs in economic evaluations of health care programmes

✍ Karin H. M. Jacob-Tacken; Marc A. Koopmanschap; Willem Jan Meerding; Johan L. Se 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 2 views

## Abstract In the economic evaluation of health care programmes, productivity costs are often estimated using patients' wages for the period of absence. However, the use of such methods for short periods of absence is controversial. A previous study found that short‐term absence is often compensat

Economic evaluation in health care: an i

Economic evaluation in health care: an introduction for psychiatrists

✍ A. McGuire; M. Drummond 📂 Article 📅 1993 🏛 Springer-Verlag 🌐 English ⚖ 882 KB

Biases in cost measurement for economic

Biases in cost measurement for economic evaluation studies in health care

✍ Philip Jacobs; Jean-François Baladi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 401 KB 👁 2 views

This paper addresses the issue of biases in cost measures which are used in economic evaluation studies. The basic measure of hospital costs which is used by most investigators is unit cost. Focusing on this measure, a set of criteria which the basic measures must fulfil in order to approximate the

Methodic principles for evaluating econo

Methodic principles for evaluating economic efficiency of metrological services in enterprises

✍ L. V. Besfamil'naya 📂 Article 📅 1976 🏛 Springer US 🌐 English ⚖ 334 KB